CD86 and neoplasm: We found that CD44+TCF-1–CD8+ T cells in the tumor after combined RT and CD86 blockade expressed PD-1, albeit to a lesser extent than did CD44+TCF-1+CD8+ T cells (Supplemental Figure 8A).